首页> 外文期刊>Pharmacoepidemiology and drug safety >Acetaminophen overdose: a little recognized public health threat.
【24h】

Acetaminophen overdose: a little recognized public health threat.

机译:对乙酰氨基酚过量:有点公认的公共卫生威胁。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent concerns regarding acetaminophen overdose have lead multiple stakeholders to collaborate towards advancing the safe use of over-the-counter (OTC) and prescription medications. Although the majority of acetaminophen overdose cases are intentional overdoses, recent reports indicate that unintentional acetaminophen overdose in the USA continues to exist.1 More importantly, unintentional overdose of acetaminophen is the overdose type most likely to result in hospitalization, liver injury, or death. The Federal Drug Administration's (FDA) Center for Drug Evaluation and Research recently held a public workshop to assess current research in the area and to foster further investigation. In addition, early this year, the FDA announced that it will be requesting modifications to current practice in two specific areas: (i) reduction of dosing per tablet or capsule of any product containing acetaminophen and (ii) requiring warnings for prescription medications containing acetaminophen.
机译:最近对乙酰氨基酚用药过量的担忧已导致多个利益相关者共同努力,以促进安全使用非处方药(OTC)和处方药。尽管大多数对乙酰氨基酚用药过量是故意用药过量,但最近的报道表明,美国对乙酰氨基酚用药过量的情况仍然存在。1更重要的是,对乙酰氨基酚用药过量的用药过量是最有可能导致住院,肝损伤或死亡的用药过量。联邦药物管理局(FDA)的药物评估和研究中心最近举行了一次公开研讨会,以评估该领域的最新研究并促进进一步的研究。此外,今年年初,FDA宣布将在两个特定领域要求对现行做法进行修改:(i)减少任何含有对乙酰氨基酚的产品的每片或每片胶囊的剂量;(ii)要求警告含有对乙酰氨基酚的处方药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号